Results 181 to 190 of about 381,827 (331)
A Structured Approach to Identifying and Addressing Drug Therapy Problems in Neonatal and Pediatric Critically Ill Patients: IN-DEPTH. [PDF]
J Pediatr Pharmacol TherMoore B, Johnson PN, Miller J.
europepmc +1 more source
Ecabet sodium, a novel locally‐acting anti‐ulcer agent, protects the integrity of the gastric mucosal gel layer from pepsin‐induced disruption in the rat [PDF]
, 1999 キノシタ +6 more
openalex +1 more source
Perioperative utilization of JAK inhibitors in Perianal Fistulizing Crohn's disease
JPGN Reports, EarlyView.Abstract With the recent approval of small molecule drugs such as upadacitinib in adult inflammatory bowel disease (IBD), their utilization is becoming more common; however, there is limited data on perioperative risks or optimal timing of cessation and resumption to mitigate flares. Current recommendations suggest holding these medications for 14 days
Alexander Lyons +2 more
wiley +1 more source
A Rare Case of Pyoderma Gangrenosum as a Complication of Ulcerative Colitis: A Case Report and Literature Review. [PDF]
Clin Case RepShah A +6 more
europepmc +1 more source
Effects of a new anti-ulcer agent (HAU-102) on experimental gastric ulcers
, 1988 Masaru Saita +4 more
openalex +1 more source
JPGN Reports, EarlyView.Abstract Acute severe ulcerative colitis increases the risk for cytomegalovirus (CMV) infection, particularly with the use of immunocompromising medications. We report a case of a 4‐year‐old with newly diagnosed very early onset inflammatory bowel disease presenting with acute severe colitis refractory to both corticosteroids and infliximab, whose ...
Alison Laxer +3 more
wiley +1 more source
Identifying essential medications for critical care: initial findings from US academic intensive care units. [PDF]
J Pharm Policy PractWireko FW, Miller A, Touray S, Sefa N.
europepmc +1 more source